TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Return 18.15%
This Quarter Return
+13.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.46B
AUM Growth
+$126M
Cap. Flow
-$109M
Cap. Flow %
-4.43%
Top 10 Hldgs %
40.31%
Holding
213
New
10
Increased
47
Reduced
69
Closed
17

Top Buys

1
PFE icon
Pfizer
PFE
$23.5M
2
MRK icon
Merck
MRK
$21.2M
3
WELL icon
Welltower
WELL
$14.9M
4
LLY icon
Eli Lilly
LLY
$10.2M
5
CELG
Celgene Corp
CELG
$8.65M

Top Sells

1
BIIB icon
Biogen
BIIB
$19.1M
2
JNJ icon
Johnson & Johnson
JNJ
$18.8M
3
ALXN
Alexion Pharmaceuticals Inc
ALXN
$16.3M
4
ABBV icon
AbbVie
ABBV
$13.9M
5
TMO icon
Thermo Fisher Scientific
TMO
$13.5M

Sector Composition

1 Healthcare 94.43%
2 Real Estate 2.93%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARWR icon
176
Arrowhead Research
ARWR
$4.02B
$563K 0.02%
30,700
– –
ATNX
177
DELISTED
Athenex, Inc. Common Stock
ATNX
$558K 0.02%
2,277
– –
CNCE
178
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$548K 0.02%
45,362
– –
EVH icon
179
Evolent Health
EVH
$1.11B
$530K 0.02%
42,150
– –
HZNP
180
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$511K 0.02%
+19,350
New +$511K
IMGN
181
DELISTED
Immunogen Inc
IMGN
$456K 0.02%
168,190
– –
DNLI icon
182
Denali Therapeutics
DNLI
$2.26B
$450K 0.02%
+19,372
New +$450K
ADYX
183
DELISTED
Adynxx, Inc. Common Stock
ADYX
$437K 0.02%
24,750
– –
CDTX icon
184
Cidara Therapeutics
CDTX
$1.6B
$421K 0.02%
7,939
– –
NVAX icon
185
Novavax
NVAX
$1.28B
$315K 0.01%
28,550
– –
CAH icon
186
Cardinal Health
CAH
$35.7B
$303K 0.01%
6,300
– –
ORKA
187
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
$303K 0.01%
3,756
– –
TRIL
188
DELISTED
Trillium Therapeutics Inc.
TRIL
$294K 0.01%
446,099
– –
CLSD icon
189
Clearside Biomedical
CLSD
$27.2M
$228K 0.01%
165,330
– –
NUVA
190
DELISTED
NuVasive, Inc.
NUVA
$217K 0.01%
3,816
-25,000
-87% -$1.42M
BLCM
191
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$202K 0.01%
6,000
– –
JNCE
192
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$63K ﹤0.01%
10,127
– –
CLDX icon
193
Celldex Therapeutics
CLDX
$1.52B
$35K ﹤0.01%
7,053
– –
QHC
194
DELISTED
Quorum Health Corporation
QHC
$33K ﹤0.01%
23,725
– –
A icon
195
Agilent Technologies
A
$36.5B
– –
-8,200
Closed -$553K
INVA icon
196
Innoviva
INVA
$1.29B
– –
-161,603
Closed -$2.82M
LMAT icon
197
LeMaitre Vascular
LMAT
$2.21B
– –
-27,150
Closed -$642K
LXRX icon
198
Lexicon Pharmaceuticals
LXRX
$396M
– –
-70,000
Closed -$465K
MTD icon
199
Mettler-Toledo International
MTD
$26.9B
– –
-3,500
Closed -$1.98M
NCNA
200
NuCana
NCNA
$5.48M
– –
-2
Closed -$142K
5 6 7
8
9